Understanding Mounjaro: What is the Dosage for Weight Loss?

Last reviewed: July 13, 2026

Last updated: July 13, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide, a dual GLP-1 and GIP receptor agonist, has emerged as a powerful tool for weight management with clinical trials showing average weight loss of 20-22% at therapeutic doses. Understanding how dosing works—and how your dose adjusts over time—helps you set realistic expectations for your weight loss journey. PlexusDx delivers personalized tirzepatide protocols from licensed 503A compounding pharmacies, with flat monthly pricing regardless of your current dose level.

How Tirzepatide Dosing Works for Weight Loss

Tirzepatide dosing follows a gradual titration schedule designed to allow your body to adapt while minimizing side effects. The standard protocol begins at 2.5 mg injected subcutaneously once weekly, with increases of 2.5 mg every four weeks if tolerated. Most patients reach therapeutic doses between 5 mg and 15 mg weekly, though some require doses up to 10 mg for optimal results. This stepped approach lets your appetite-regulating pathways adjust progressively rather than shifting dramatically.

The dosing ladder is not one-size-fits-all—individual factors including your starting weight, metabolic rate, and how your body responds determine your ideal maintenance dose. Some people experience significant appetite suppression at 5 mg weekly, while others benefit from advancing to 10 mg or higher. PlexusDx works with you to establish the right starting point and creates a personalized advancement plan. Your dose may need to go up. Your price won't. All PlexusDx tirzepatide injections maintain flat monthly pricing at $289/mo (or $249/mo on the 6-month plan) regardless of which dose level you're currently taking.

Tirzepatide Dose Escalation and Weight Loss Results

Clinical trials show that weight loss results correlate with dose level, but benefits begin appearing even at lower doses. Participants taking 5 mg weekly averaged 10-12% weight loss over 68 weeks, while those on 10 mg achieved approximately 20% weight loss, and the highest approved dose (15 mg) produced mean weight loss of 22%. This dose-dependent response reflects how tirzepatide's dual mechanism—activating both GLP-1 and GIP pathways—intensifies appetite control and metabolic improvements as doses increase.

However, reaching maximum dose is not necessary for meaningful results. Many patients achieve their weight loss goals and maintain them at 5-7.5 mg weekly. The key is finding your optimal dose—the level where you experience appetite suppression and steady fat loss while tolerating side effects well. PlexusDx's approach focuses on sustainable dosing rather than rushing to maximum levels, because consistency and tolerability matter more than dose size for long-term success.

Starting Tirzepatide and Dose Titration Timeline

Beginning tirzepatide typically means starting low and advancing gradually over 16-24 weeks to reach your target dose. Week 1-4: You inject 2.5 mg once weekly. During this phase, your body begins responding to GLP-1 and GIP signaling, often reducing hunger and food cravings within days to a week. Week 5-8: If tolerated, your dose increases to 5 mg weekly—the point where most patients notice significant appetite suppression. Week 9-12: Another advance to 7.5 mg weekly strengthens the effect further. This timeline allows your gastrointestinal system to adapt and helps you identify your ideal dose before side effects become problematic.

If you experience nausea or reduced appetite that feels too strong at any level, you may stay at that dose longer or advance more slowly. Some people plateau at 5 mg and achieve excellent results without further increases. PlexusDx providers work with you to track your progress at each step, adjusting your timeline based on how you feel and your weight loss trajectory. The goal is reaching a maintenance dose that you can sustain comfortably—not simply pushing to the highest approved level.

Genetic Factors That Influence Your Tirzepatide Dosing Needs

Your genetic makeup shapes how effectively tirzepatide works and what dose you'll likely need for optimal results. Key genetic variants in GLP-1 receptor pathways (like GLP1R rs6923761), GIP receptor genes (GIPR rs1800437), and appetite-regulation genes (FTO rs9939609, MC4R rs17782313) influence how strongly you respond to tirzepatide at any given dose. Some people carry genetic variations that make them highly sensitive to tirzepatide's effects, requiring lower doses to achieve significant weight loss. Others may need higher doses to activate the same pathways effectively.

PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after your first month of treatment) to map 14 metabolic pathways across 49 peptides and 150+ genetic insights specific to GLP-1 and GIP signaling. This test identifies your genetic predispositions for peptide sensitivity, helping your provider craft a dosing strategy aligned with your biology rather than generic protocols. Patients who understand their genetic peptide profile often achieve results faster and experience fewer dose adjustments because their initial dose matches their neurobiological needs.

PlexusDx Tirzepatide Pricing and Access

PlexusDx compounded tirzepatide injections are $289/mo month-to-month, or from $249/mo on the 6-month plan and remain at that flat rate regardless of your current dose—whether you're taking 2.5 mg or 15 mg weekly. This pricing model removes the financial barrier that often discourages patients from advancing their dose when medically appropriate. Many traditional weight loss programs charge per-dose or use dose ladders that increase costs as you progress, creating a perverse incentive to stay at suboptimal doses for financial reasons. PlexusDx eliminates that conflict by committing to one price across your entire dosing journey.

All PlexusDx tirzepatide comes from licensed 503A compounding pharmacies, ensuring pharmaceutical-grade quality and consistency. The service is available in all 50 states without insurance requirements or membership fees. Treatment qualifies for HSA and FSA accounts, making compounded tirzepatide even more accessible. Your dose may need to go up. Your price won't. This commitment reflects PlexusDx's philosophy that affordability should never limit your ability to reach your optimal therapeutic dose.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the starting dose of tirzepatide for weight loss?

Tirzepatide weight loss treatment typically begins at 2.5 mg injected subcutaneously once weekly. This starting dose allows your body to adapt to GLP-1 and GIP pathway activation while you assess your tolerance. Most patients advance by 2.5 mg increments every four weeks until reaching their optimal dose, usually between 5-10 mg weekly.

How much weight can you lose on tirzepatide at different doses?

Clinical trial data shows dose-dependent weight loss: 5 mg weekly produces approximately 10-12% weight loss, 10 mg achieves around 20% weight loss, and 15 mg (highest approved dose) results in average weight loss of 22% over 68 weeks. Individual results vary based on genetics, lifestyle, and how long you've been taking the medication.

Does PlexusDx charge more money if my tirzepatide dose increases?

No. PlexusDx compounded tirzepatide injections maintain flat monthly pricing at $289/mo (or $249/mo on the 6-month plan) regardless of your dose level. Your dose may need to go up. Your price won't. This commitment ensures affordability remains consistent whether you're at 2.5 mg or 15 mg weekly.

What are common side effects of tirzepatide at higher doses?

Nausea is the most frequently reported side effect, occurring more often at higher doses or during dose escalation. Other common effects include reduced appetite (intended), occasional vomiting, constipation, and abdominal discomfort. Most side effects diminish within 1-2 weeks as your body adapts. Gradual dose titration minimizes symptom severity and helps distinguish between adaptation and true intolerance.

How does the Precision Peptide Genetic Test help with my tirzepatide dose?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Mounjaro For Weight Loss 2
• Glp 1 Dosage For Weight Loss
• Weight Loss Mounjaro
• Mounjaro Weight Loss By Week

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.